Australia markets open in 3 hours 39 minutes

Fulgent Genetics, Inc. (FLGT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
24.06-0.22 (-0.91%)
At close: 04:00PM EST
23.85 -0.21 (-0.87%)
After hours: 08:00PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 712.97M
Enterprise value 248.06M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.52
Price/book (mrq)0.57
Enterprise value/revenue 0.87
Enterprise value/EBITDA -4.81

Trading information

Stock price history

Beta (5Y monthly) 1.50
52-week change 3-26.35%
S&P500 52-week change 327.79%
52-week high 344.09
52-week low 323.09
50-day moving average 326.91
200-day moving average 331.03

Share statistics

Avg vol (3-month) 3188.69k
Avg vol (10-day) 3192.02k
Shares outstanding 529.63M
Implied shares outstanding 629.63M
Float 819.57M
% held by insiders 131.57%
% held by institutions 149.61%
Shares short (31 Jan 2024) 4469.87k
Short ratio (31 Jan 2024) 43.33
Short % of float (31 Jan 2024) 42.81%
Short % of shares outstanding (31 Jan 2024) 41.59%
Shares short (prior month 29 Dec 2023) 4551.89k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023


Profit margin -22.17%
Operating margin (ttm)0.25%

Management effectiveness

Return on assets (ttm)-3.01%
Return on equity (ttm)-5.11%

Income statement

Revenue (ttm)286.41M
Revenue per share (ttm)9.63
Quarterly revenue growth (yoy)-19.80%
Gross profit (ttm)N/A
Net income avi to common (ttm)-63.51M
Diluted EPS (ttm)-2.10
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)467.8M
Total cash per share (mrq)15.79
Total debt (mrq)20M
Total debt/equity (mrq)1.59%
Current ratio (mrq)8.95
Book value per share (mrq)41.91

Cash flow statement

Operating cash flow (ttm)45.28M
Levered free cash flow (ttm)27.04M